FDA Adverse Event Malfunction Summary report: N

PARADIGM REAL-TIME INSULIN INFUSION PUMP

MDR report key: 3192666 · Received June 27, 2013

Report

Report Number
2032227-2013-02589
Event Type
Malfunction
Date Received
June 27, 2013
Date of Event
June 3, 2013
Report Date
June 3, 2013
Manufacturer
MEDTRONIC MINIMED
Product Code
OYC
PMA / PMN Number
P980022
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WV
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT. THE DEVICE HAS BEEN RETURNED, BUT NOT YET EVALUATED. FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME.

Additional Manufacturer Narrative · 1

THE INSULIN PUMP RECEIVED WITH OPERATING CURRENTS WITHIN SPECIFICATION. THE INSULIN PUMP PASSED SELF TEST, ERROR TEST AND DISPLACEMENT TEST. UNABLE TO PRIME THE INSULIN PUMP DURING THE PRIME TEST AND MOTOR ERROR ALARMS DURING BASIC OCCLUSION TEST DUE TO FAULTY FORCE SENSOR. UNABLE TO PERFORM OCCLUSION TEST OR EXCESSIVE NO DELIVERY TEST DUE TO PRIME ANOMALY. THE MOTOR WAS TESTED OUTSIDE THE DEVICE AND PASSED. THE DRIVE SUPPORT DISK WAS INSPECTED AND NO ANOMALY WAS NOTED. THE INSULIN PUMP WAS RECEIVED WITH A SCRATCH LCD WINDOW.

Description of Event or Problem · 1

THE CUSTOMER STATED THAT THE INSULIN PUMP GAVE SEVERAL MOTOR ERROR ALARMS. THE INSULIN PUMP WAS NOT EXPOSED TO HIGH MAGNETIC FIELDS. TROUBLESHOOTING WAS PERFORMED, AND THE INSULIN PUMP PASSED THE DISPLACEMENT AND SELF TESTS. THE CUSTOMER INSPECTED THE DRIVE SUPPORT CAP, AND HE STATED IT WAS NOT FLUSH OR PROTRUDED, BUT IT WAS SLIGHTLY UNEVEN. ADVISED THE CUSTOMER THAT THE INSULIN PUMP WOULD BE REPLACED TO BE ON THE SAFE SIDE. NOTHING FURTHER WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
294645 PARADIGM REAL-TIME INSULIN INFUSION PUMP INSULIN INFUSION PUMP / SENSOR AUGMENTED OYC MEDTRONIC MINIMED MMT-722LNAS

Patients

Seq Age Sex Outcome Treatment
1 40 YR